Our Research

16 Nov 2021 Better Than Average

Posted at 13:41 in Research by Max Theiler

Can Courts Rely On Benchmark Figures For Cartel Overcharges?...

24 Sep 2021 The Antitrust Case Against The Loyalty Penalty

Posted at 09:28 in Research by Chris Pike

Defining Markets For Loyal Customers...

24 Aug 2021 Was The UK Vaccine Rollout Discriminatory?

Posted at 13:32 in Research by Ellie House

No - it was the picture of fairness...

16 Aug 2021 An Epic Judgement

Posted at 09:24 in Research by Chris Pike

Economic Review Of The Epic V Apple Landmark Case...

13 Aug 2021 He’s making a list, and checking it twice

Posted at 13:45 in Research by Chris Pike

Who's been naughty and nice in 2021...

31 Jul 2021 Covid-19 Travel Tests Investigation

Posted at 15:20 in Research by Paul Vella

Unavailable And Inaccessible...

25 Jun 2021 Can Algorithms Discriminate?

Posted at 15:51 in Research by Paul Vella

Fideres Investigates Algorithmic Mortgage Discrimination In The US...

12 Apr 2021 Pre-Arranged Bids On Prepaid Cards

Posted at 12:54 in Research by Alberto Thomas

Assessing The Impact Of The Cartel Allegations...

01 Jul 2020 Marching Backwards

Posted at 12:58 in Research by Dato Aronia

The Emerging Pro-Defendant Class Action Landscape...

20 Jun 2020 ETFs: Small Fees, Big Issues

Posted at 15:36 in Research by Dato Aronia

Inefficiencies And Potential Competition Issues...

26 Mar 2020 Storm Clouds Over The CLO Market

Posted at 15:32 in Research by Alberto Thomas

Fideres Analyses The Potential Impact Of Covid-19 On The CLO Market...

20 Mar 2020 Title Insurance: Excessive Premiums

Posted at 11:04 in Research by Alberto Thomas

A Lack Of Competition In The Title Insurance Market In Unregulated US States...

03 Mar 2020 Putting A Price On Consumer Data

Posted at 08:07 in Research by Max Theiler

Damage Estimation In Data Breach Litigation...

16 Jan 2020 Underwriting in US Bond Markets

Posted at 15:54 in Research by Paul Vella

Why the Status Quo Poses Risks to Competition...

16 Dec 2019 Fideres’s Christmas Investigation

Posted at 15:57 in Research by Rahul Muralidharan

Travel Price Discrimination...

02 Dec 2019 Market Power In The Ivory Tower

Posted at 12:36 in Research by Rahul Muralidharan

Evidence Of Collusive Behaviour In Academic Publishing...

28 Nov 2019 Pipe Dreams

Posted at 11:11 in Research by Max Theiler

UK Drainage Cartel...

10 Oct 2019 New York Taxi Medallions

Posted at 14:17 in Research by Robert Chang

Another Rough Ride For Financial Institutions?...

23 Jul 2019 Passing-On Eulogy

Posted at 13:37 in Research by Chris Pike

Evidence Of Collusive Behaviour In Academic Publishing...

15 Jul 2019 British Airways’ Data Breach

Posted at 15:08 in Research by Max Theiler

As GDPR Takes Off, UK Litigators May Become Frequent Filers...

24 Jun 2019 Dirty Copper!

Posted at 15:38 in Research by Robert Chang

Fideres's Two Cents On The Copper Fix...

04 Jun 2019 Clearing The Air

Posted at 10:45 in Research by Max Theiler

Automotive Cartels And Emissions Technology...

29 Apr 2019 Crossed Wires

Posted at 11:02 in Research by Max Theiler

Key Points The United States (“US”) has some of the most expensive wireless plans in the developed world: the average price for 1 gigabyte (“GB”) of data was twice the OECD average in 2018 The mobile network market is highly vertically integrated, which presents competition...

11 Mar 2019 Metro Bank’s Accounts

Posted at 16:02 in Research by Robert Chang

Mind The Gap...

04 Mar 2019 Trust Issues In Bond Markets

Posted at 16:40 in Research by Michele Pau

Are Underwriters Using Their Relationships With Issuers To Distort Prices?...

18 Feb 2019 Keeping Your Options Open

Posted at 16:02 in Research by Steffen Hennig

Damages In 10b-5 Claims...

29 Jan 2019 Pay-To-Delay For Biosimilars

Posted at 16:47 in Research by Max Theiler

Key Findings Biosimilar drugs are non-generic alternatives to traditional biologic medicines, that sell at a fraction of the price Scrutiny of pay-to-delay cases in the pharmaceutical market has increased following the emergence of biosimilars competing with complex biologic medicines In this Research Alert, Fideres outlines...